Reinvestigates aspects of experimental and clinical evidence in these two mental disorders on the basis of new concepts. A number of renowned authorities contribute articles concerned with recent discoveries involving specific neurotransmitters. Coverage includes tests to predict antidepressant actions, neurochemical and neuropharmaceutical prospects, biochemical effects of antidepressant and anxiolytic drugs on receptor mechanisms, common noradrenergic dysfunction in these ailments, the potential importance of dopamine and much more.
